Newsroom
Vascudyne Receives BioBusiness Award from Regenerative Medicine Minnesota for Treatment of Nerve Injury
Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference
Regenerative Medicine Company Vascudyne Relocates to High Capacity GMP Manufacturing Facility
Vascudyne’s TRUE Tissue Technology is a Top 3 2022 Better World Project Award Finalist
Regenerative Medicine Company Vascudyne Closes $10M Series A Financing
Vascudyne announces successful First Human Use of TRUE™ Vascular Graft for hemodialysis access
Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb
Lab-created heart valves can grow with the recipient article published in Science Translational Medicine
Vascudyne is awarded Regenerative Medicine Minnesota grant on transcatheter regenerative tissue pulmonary valve project
Vascudyne exhibits at DeviceTalks in Minnesota
Vascudyne’s CSO presents at the Heart Valve Society Meeting on engineered tissue transcatheter valve for pulmonary and tricuspid valve implant
Vascudyne is awarded Regenerative Medicine Minnesota grant on development of regenerative engineered tissue embedded cardiovascular device project
University of Minnesota startup Vascudyne to commercialize biologic engineered tissue with potential to transform medical device technology
New tissue-engineered blood vessel replacements closer to human trials article published in Science Translational Medicine
Artificial blood vessels developed in the lab can grow with the recipient article published in Nature Communications
Proud Member of:
Copyright 2021 | Vascudyne, Inc.
